COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Medical Marijuana Use in HIV+ Patients Prospective Cohort Study (MMC-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01536899
Recruitment Status : Completed
First Posted : February 22, 2012
Last Update Posted : April 5, 2018
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Mark Greenwald, PhD, Wayne State University

Brief Summary:

The investigators are interested in understanding personal factors such as medical conditions and mental health, as well as social and economic factors, that influence marijuana (and other substance) use in HIV-positive patients.

Several alternative hypotheses will be evaluated in the proposed project:

  1. healthier patients may self-select marijuana use;
  2. marijuana use may be associated with consequences that create barriers to seeking healthcare;
  3. marijuana use may have medicinal value that reduces the need for such care.

Condition or disease
HIV Positive Marijuana Smoking

Detailed Description:

The study will involve a total of 5 interviews with clinical research staff members, the total involvement will be for about 1 year.

The first interview will establish a baseline of current behaviors and health status; this will take about 3-4 hours. This interview will take place at the Tolan Park Medical Building, located at 3901 Chrysler Service Dr. The remaining 4 interviews - which will be shorter in length - will be conducted about 3, 6, 9, and 12 months after the baseline interview; each follow-up interview will take about 2 hours.The purpose of the 4 remaining interviews is to assess changes in behaviors and health status over time.

We will collect urine samples at each of the 5 interview sessions to assess health and illicit drug use.

Layout table for study information
Study Type : Observational
Actual Enrollment : 119 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Behavioral Economic Analysis of Medical Marijuana Use in HIV+ Patients Prospective Cohort Study
Study Start Date : February 2012
Actual Primary Completion Date : June 2017
Actual Study Completion Date : June 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: HIV/AIDS Marijuana

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
HIV positive and marijuana using volunteers

Inclusion Criteria:

  • Participants will be patients in the HIV clinic.
  • Participants will have HIV.
  • Participants will sign a single consent form.
  • Participants will be marijuana users.

Exclusion Criteria:

  • Participants who test negative for marijuana will be excluded.
  • Volunteers who exhibit signs of drug intoxication or cognitive/mental impairment during the consent process will be excluded.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01536899

Layout table for location information
United States, Michigan
Wayne State University (HIV clinic, Tolan Park Medical Buiding)
Detroit, Michigan, United States, 48201
Sponsors and Collaborators
Wayne State University
National Institute on Drug Abuse (NIDA)
Layout table for investigator information
Principal Investigator: Mark Greenwald, PhD Wayne State University

Layout table for additonal information
Responsible Party: Mark Greenwald, PhD, Professor, Wayne State University Identifier: NCT01536899    
Other Study ID Numbers: MMC-1
R01DA032678 ( U.S. NIH Grant/Contract )
First Posted: February 22, 2012    Key Record Dates
Last Update Posted: April 5, 2018
Last Verified: April 2018
Keywords provided by Mark Greenwald, PhD, Wayne State University:
HIV positive
Medical Marijuana
Additional relevant MeSH terms:
Layout table for MeSH terms
HIV Seropositivity
Marijuana Abuse
Marijuana Use
HIV Infections
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders